Q-Safety Inc.

Teletouch Regains Current Reporting Status after Filing Previously Delinquent Quarterly Reports on Form 10-Q for the 2008 Fiscal Year Period; Teletouch Cautions Investors Not to Rely on These Dated Financial Presentations.(Financial report)
Business Wire; 12/24/2009; 1545 words; ...QUARTERLY REPORTS ON FORMS 10-Q FOR THE PERIODS ENDED AUGUST...Progressive Concepts, Inc. ("PCI"), for each...Quarterly Reports on Form 10-Q brings the Company into...wireless messaging and public safety/emergency response products...Progressive Concepts, Inc. (PCI), is a leading...

Pfizer's Lyrica Receives Complete Response Letter From FDA For Generalized Anxiety Disorder Monotherapy Treatment.
Business Wire; 12/24/2009; 815 words; NEW YORK -- Pfizer Inc. (NYSE: PFE) announced today...treatment options." Pfizer Inc.: Working together for a healthier...set the standard for quality, safety and value in the discovery...and in its reports on Form 10-Q and Form 8-K.

Xenonics Reports 91% Increase in Fourth Quarter Revenue.(Financial report)
Business Wire; 12/22/2009; 886 words; ...XENONICS HOLDINGS, INC. (NYSE AMEX:XNN) announced...with Aardvark Tactical, Inc. (ATI) for Xenonics...Xenonics Xenonics Holdings, Inc. (AMEX:XNN) develops...law enforcement, public safety, and commercial and private...on Form 10-K and 10-Q and other filings with...

Poniard Pharmaceuticals Announces $6.5 Million Financing.
PR Newswire Europe; 12/22/2009; 1096 words; ...picoplatin has an improved safety profile relative to existing...completed a Phase 1 cardiac safety trial of picoplatin and...at all, the potential safety and efficacy of the Company...Quarterly Report on Form 10-Q for the period ended September...Poniard Pharmaceuticals, Inc. All Rights ...

PharmAthene Appoints Jeffrey W. Runge, M.D. to the Company's Board of Directors.
PR Newswire; 12/21/2009; 1058 words; ...About PharmAthene, Inc. PharmAthene was formed...studies relating to human safety and possible adverse effects...competitors, unforeseen safety issues, challenges related...Forms 10-K and 10-Q under the caption "Risk...Jurchison of PharmAthene, Inc., +1-410-